Mon, Oct 20, 2014, 7:29 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Prima Biomed Ltd. Message Board

  • trendstok trendstok Oct 19, 2012 12:14 AM Flag

    Ord Minnett Research about Prima BioMed Limited

    Prima BioMed (PRR) has released interim data from the CAN-003 trial (a 63 patient Phase IIb study) ahead of a meeting of the International Gynaecologic Cancer Society in Vancouver, Canada. The key data points can be grouped into three categories:
    - Safety
    - Efficacy
    - Biological Activity

0.98-0.02(-2.00%)Oct 20 2:16 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.